Snowball logo
logo
CYCC_logo

Cyclacel Pharmaceuticals Inc

CYCCP NASDAQ
$6.00$0.00  (0%)
Estimate
EPS
-2.047
Beta
0.156
About the company
Ticker
CYCCP
ISIN
US23254L2079
Country
United States of America
Sector (GICS)
Healthcare
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.

Frequently asked questions

What sector does Cyclacel Pharmaceuticals Inc (CYCCP) operate in?

Cyclacel Pharmaceuticals Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Cyclacel Pharmaceuticals Inc (CYCCP) current stock price?

As of the latest data, Cyclacel Pharmaceuticals Inc stock price is $6.00, with a previous close of $6.00.

What is Cyclacel Pharmaceuticals Inc (CYCCP) current market capitalization?

Cyclacel Pharmaceuticals Inc market cap is approximately 74.98 million.

What is Cyclacel Pharmaceuticals Inc (CYCCP) Earnings Per Share (EPS)?

The trailing EPS is -$2.05.

Does Cyclacel Pharmaceuticals Inc (CYCCP) pay dividends?

No. Cyclacel Pharmaceuticals Inc does not pay a dividend.

What is Cyclacel Pharmaceuticals Inc (CYCCP) beta (volatility) score?

Cyclacel Pharmaceuticals Inc has a beta of 0.156, indicating lower volatility than the overall market.